Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
International Journal of Molecular and Cellular Medicine
|
November 4, 2024
Extracellular Signal-Regulated Kinase Inhibitor SCH772984 Augments the Anti-Cancer Effects of Gemcitabine in Nanoparticle Form in Pancreatic Cancer Models
Gauthami G Nair, Elena D Linster, Priyanka Ray, et al.
ACS Biomaterials Science & Engineering
|
January 6, 2021
Size-Transformable, Multifunctional Nanoparticles from Hyperbranched Polymers for Environment-Specific Therapeutic Delivery
Priyanka Ray, Lina Alhalhooly, Arnab Ghosh, et al.
ACS Nano
|
March 11, 2024
Context-Responsive Nanoparticle Derived from Synthetic Zwitterionic Ionizable Phospholipids in Targeted CRISPR/Cas9 Therapy for Basal-like Breast Cancer
Parikshit Moitra, David Skrodzki, Matthew Molinaro, et al.
Journal of Cell Communication and Signaling
|
March 28, 2019
Microenvironment-sensing, nanocarrier-mediated delivery of combination chemotherapy for pancreatic cancer
Priyanka Ray, Gauthami Nair, Arnab Ghosh, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
January 28, 2016
A New, Simple and Versatile Strategy for the Synthesis of Short Segments of Zigzag-Type Carbon Nanotubes
Etienne André, Baptiste Boutonnet, Pauline Charles, et al.
Pharmacology Research & Perspectives
|
March 21, 2021
CCN5 activation by free or encapsulated EGCG is required to render triple-negative breast cancer cell viability and tumor progression
Amlan Das, Inamul Haque, Priyanka Ray, et al.
Molecular Pharmaceutics
|
June 11, 2020
Targeting the Tumor Core: Hypoxia-Responsive Nanoparticles for the Delivery of Chemotherapy to Pancreatic Tumors
Matthew I Confeld, Babak Mamnoon, Li Feng, et al.
Plos One
|
April 30, 2024
pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant K-Ras-addicted pancreatic cancer cells and mouse model
Debasmita Dutta, Priyanka Ray, Archana De, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
May 31, 2023
Vaxi-DL: An Artificial Intelligence-Enabled Platform for Vaccine Development
P Preeti, Swarsat Kaushik Nath, Nevidita Arambam, et al.
Biorxiv : the Preprint Server for Biology
|
April 8, 2024
Design and Evaluation of Nanoscale Materials with Programmed Responsivity towards Epigenetic Enzymes
Priyanka Ray, Abbas Sedigh, Matthew Confeld, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
International Journal of Molecular and Cellular Medicine
|
November 4, 2024
Extracellular Signal-Regulated Kinase Inhibitor SCH772984 Augments the Anti-Cancer Effects of Gemcitabine in Nanoparticle Form in Pancreatic Cancer Models
Gauthami G Nair, Elena D Linster, Priyanka Ray, et al.
ACS Biomaterials Science & Engineering
|
January 6, 2021
Size-Transformable, Multifunctional Nanoparticles from Hyperbranched Polymers for Environment-Specific Therapeutic Delivery
Priyanka Ray, Lina Alhalhooly, Arnab Ghosh, et al.
ACS Nano
|
March 11, 2024
Context-Responsive Nanoparticle Derived from Synthetic Zwitterionic Ionizable Phospholipids in Targeted CRISPR/Cas9 Therapy for Basal-like Breast Cancer
Parikshit Moitra, David Skrodzki, Matthew Molinaro, et al.
Journal of Cell Communication and Signaling
|
March 28, 2019
Microenvironment-sensing, nanocarrier-mediated delivery of combination chemotherapy for pancreatic cancer
Priyanka Ray, Gauthami Nair, Arnab Ghosh, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
January 28, 2016
A New, Simple and Versatile Strategy for the Synthesis of Short Segments of Zigzag-Type Carbon Nanotubes
Etienne André, Baptiste Boutonnet, Pauline Charles, et al.
Pharmacology Research & Perspectives
|
March 21, 2021
CCN5 activation by free or encapsulated EGCG is required to render triple-negative breast cancer cell viability and tumor progression
Amlan Das, Inamul Haque, Priyanka Ray, et al.
Molecular Pharmaceutics
|
June 11, 2020
Targeting the Tumor Core: Hypoxia-Responsive Nanoparticles for the Delivery of Chemotherapy to Pancreatic Tumors
Matthew I Confeld, Babak Mamnoon, Li Feng, et al.
Plos One
|
April 30, 2024
pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant K-Ras-addicted pancreatic cancer cells and mouse model
Debasmita Dutta, Priyanka Ray, Archana De, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
May 31, 2023
Vaxi-DL: An Artificial Intelligence-Enabled Platform for Vaccine Development
P Preeti, Swarsat Kaushik Nath, Nevidita Arambam, et al.
Biorxiv : the Preprint Server for Biology
|
April 8, 2024
Design and Evaluation of Nanoscale Materials with Programmed Responsivity towards Epigenetic Enzymes
Priyanka Ray, Abbas Sedigh, Matthew Confeld, et al.
Page
of 3